化疗会使先前 COVID-19 感染已康复的癌症患者体内的 SARS-CoV-2 重新激活吗？
Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection?
机构信息
Dept of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jianping Bi, Hong Ma and Dongsheng Zhang contributed equally as first authors.
出版信息
Eur Respir J. 2020 Oct 22;56(4). doi: 10.1183/13993003.02672-2020. Print 2020 Oct.
Abstract
摘要
[医学文献链接]
相似文献
1
Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection?化疗会使先前 COVID-19 感染已康复的癌症患者体内的 SARS-CoV-2 重新激活吗？
Eur Respir J. 2020 Oct 22;56(4). doi: 10.1183/13993003.02672-2020. Print 2020 Oct.
2
Covid-19 antibody tests: a briefing.新冠病毒-19抗体检测：简报
BMJ. 2020 Jun 24;369:m2284. doi: 10.1136/bmj.m2284.
3
Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.2019冠状病毒病大流行期间24例出现冻疮样病变患者的严重急性呼吸综合征冠状病毒2抗体评估
J Am Acad Dermatol. 2020 Dec;83(6):1753-1755. doi: 10.1016/j.jaad.2020.08.049. Epub 2020 Aug 18.
4
A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.一名严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体多次检测不到的新型冠状病毒肺炎（COVID-19）患者。
J Appl Lab Med. 2020 Nov 1;5(6):1401-1405. doi: 10.1093/jalm/jfaa137.
5
Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19.美国微生物学会2020年3月23日新型冠状病毒肺炎国际峰会报告：严重急性呼吸综合征冠状病毒2型/新型冠状病毒肺炎诊断检测的价值
mBio. 2020 Mar 26;11(2):e00722-20. doi: 10.1128/mBio.00722-20.
6
The Detection of Novel Coronavirus Antibodies is an Important Supplementary Detection Method for Screening of High-Risk Population.新型冠状病毒抗体检测是筛查高危人群的重要补充检测方法。
Clin Lab. 2020 Jul 1;66(7). doi: 10.7754/Clin.Lab.2020.200504.
7
Sensitivity of point-of-care IgM and IgG test in critically ill patients with SARS-Cov-2.即时检测SARS-CoV-2重症患者中IgM和IgG的敏感性
Crit Care. 2020 Sep 24;24(1):573. doi: 10.1186/s13054-020-03290-x.
8
COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges.新冠病毒免疫护照与疫苗接种证书：科学、公平及法律挑战
Lancet. 2020 May 23;395(10237):1595-1598. doi: 10.1016/S0140-6736(20)31034-5. Epub 2020 May 4.
9
Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study.新型冠状病毒感染临床病程中的病毒学、特异性抗体反应和影像学变化：一项描述性研究。
BMC Infect Dis. 2020 Nov 10;20(1):818. doi: 10.1186/s12879-020-05549-8.
10
Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.SARS-CoV-2 血清学检测：关注、机遇与未来方向。
Sci Immunol. 2020 May 19;5(47). doi: 10.1126/sciimmunol.abc6347.
引用本文的文献
1
Prognostic Factors for Survival or Severity After COVID-19 Infection in Cancer Patients: A Systematic Review and Meta-Analysis.癌症患者感染新型冠状病毒肺炎后的生存或严重程度的预后因素：一项系统评价和荟萃分析
J Rhinol. 2023 Jul;30(2):69-79. doi: 10.18787/jr.2023.00015. Epub 2023 Jul 28.
2
Synthesis, characterization, molecular docking, and anticancer activities of new 1,3,4-oxadiazole-5-fluorocytosine hybrid derivatives.新型1,3,4-恶二唑-5-氟胞嘧啶杂化衍生物的合成、表征、分子对接及抗癌活性
J Mol Struct. 2022 Sep 9:134135. doi: 10.1016/j.molstruc.2022.134135.
3
The Deadly Duo of COVID-19 and Cancer!新冠病毒与癌症的致命组合！
Front Mol Biosci. 2021 Apr 12;8:643004. doi: 10.3389/fmolb.2021.643004. eCollection 2021.
4
Symptomatic Reinfection in Previously Recovered Coronavirus Disease 2019 (COVID-19) Geriatric Patient.既往康复的2019冠状病毒病（COVID-19）老年患者出现症状性再次感染
Cureus. 2021 Mar 17;13(3):e13961. doi: 10.7759/cureus.13961.
本文引用的文献
1
Diagnostic efficacy of anti-SARS-CoV-2 IgG/IgM test for COVID-19: A meta-analysis.新型冠状病毒 IgG/IgM 抗体检测对 COVID-19 的诊断效能：一项荟萃分析。
J Med Virol. 2021 Jan;93(1):366-374. doi: 10.1002/jmv.26211. Epub 2020 Jul 11.
2
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.接受化疗或其他抗癌治疗的癌症患者的 COVID-19 死亡率：一项前瞻性队列研究。
Lancet. 2020 Jun 20;395(10241):1919-1926. doi: 10.1016/S0140-6736(20)31173-9. Epub 2020 May 28.
3
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.COVID-19 对癌症患者的临床影响（CCC19）：一项队列研究。
Lancet. 2020 Jun 20;395(10241):1907-1918. doi: 10.1016/S0140-6736(20)31187-9. Epub 2020 May 28.
4
COVID-19 and liver dysfunction: A systematic review and meta-analysis of retrospective studies.COVID-19 与肝功能障碍：回顾性研究的系统评价和荟萃分析。
J Med Virol. 2020 Oct;92(10):1825-1833. doi: 10.1002/jmv.26055. Epub 2020 Jul 27.
5
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.新型冠状病毒病 2019（COVID-19）大流行期间癌症患者管理的实用方法：国际协作组。
Oncologist. 2020 Jun;25(6):e936-e945. doi: 10.1634/theoncologist.2020-0213. Epub 2020 Apr 27.
6
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China.COVID-19 感染癌症患者的临床特征：中国武汉三家医院的回顾性病例研究。
Ann Oncol. 2020 Jul;31(7):894-901. doi: 10.1016/j.annonc.2020.03.296. Epub 2020 Mar 26.
7
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).COVID-19 患者的致命结局对心血管的影响。
JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.
8
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
9
Positive RT-PCR Test Results in Patients Recovered From COVID-19.新冠病毒感染者康复后出现 RT-PCR 检测结果阳性。
JAMA. 2020 Apr 21;323(15):1502-1503. doi: 10.1001/jama.2020.2783.
10
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
Zotero 插件